Aclaris Therapeutics, Inc.
ACRS
A reverse discounted cash flow for Aclaris Therapeutics, Inc. needs a live price.
That is the one figure on this site that costs money to fetch, so it runs on an account rather than on a page anybody can open. It starts from what the company has actually filed: the 2025 revenue and margin on its own statements. It asks what growth the current price is already assuming.
Valuation
Seeded from ACRS’s own filed revenue, margin and trading multiples, against a live price. An account is what lets this run, for the reason above.
Sign in to run it on Aclaris Therapeutics, Inc.Run the numbers on Aclaris Therapeutics, Inc. yourself.
Ten seconds. No card. Nothing to cancel.
What an account lets you do with Aclaris Therapeutics, Inc.
Run the model forward, then flip it
Set the assumptions for Aclaris Therapeutics, Inc. (margin, growth, multiple) and see the price they produce. Three runs free on this account, ever, no card.
Hold the price, solve for growthMeasure
See every filed year, not just the recent ones
The statements this company has actually filed, in the way it filed them.
Every year on recordMeasure
Ask about any of it, get the filing back
The assistant answers from this company's own statements, and links every figure straight to its source.
Free, no card, and it does not expire.